Velindre Cancer Centre
In research, Velindre Cancer Centre stands highest in Medicine (#3,583 of 17,978 worldwide) and Health Sciences (#4,773 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Medicine and Health Sciences — Medicine is 3.8× its share of world research.
- World rank, all time
- #11,338 of 42,892
- Rank in United Kingdom
- #630 of 2,253
- Research works
- 623 ▼ 44% vs 2013–17
- Citations
- 15k 24.4 per fractional work
- Top-10% rate
- 13.3% record average 16.5%
- Open access
- 30% world 28%
What is Velindre Cancer Centre known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #3,583 of 17,978 | 15.8% | 432 | |
| Health SciencesDomain | #4,773 of 20,462 | 15.6% | 455 |
Each strip is that field’s whole ranked pool, with the notch where Velindre Cancer Centre sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Velindre Cancer Centre specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.8× the share of its output that it takes of world research.
- MedicineField · 38.5 works3.8×
- Health SciencesDomain · 41.1 works3.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.
- Medicine 3.8×
- Health Professions 1.8×
- Biochemistry, Genetics and Molecular Biology 1.7×
- Immunology and Microbiology 1.4×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Economics, Econometrics and Finance 0.7×
- Physics and Astronomy 0.6×
- Mathematics 0.5×
- Psychology 0.5×
- Nursing 0.4×
- Computer Science 0.2×
- Materials Science 0.1×
- Engineering 0.1×
- Neuroscience 0.1×
- Social Sciences 0.1×
- Chemistry 0.1×
- Business, Management and Accounting 0.1×
- Decision Sciences 0.1×
- Environmental Science 0.0×
Who are the top researchers at Velindre Cancer Centre?
Ranked on the composite score, Peter Barrett‐Lee, Richard Adams and Satish Kumar lead among researchers whose main affiliation is Velindre Cancer Centre.
- 1 Peter Barrett‐Lee United Kingdom · #160,634 worldwide 134 citations · 30 works
- 2 Richard Adams United Kingdom · #426,795 worldwide 162 citations · 81 works
- 3 Satish Kumar United Kingdom · #699,097 worldwide 33 citations · 25 works
- 4 J. Staffurth United Kingdom · #836,758 worldwide 21 citations · 29 works
- 5 Ricky Frazer United Kingdom · #900,627 worldwide 29 citations · 15 works
- 6 Sarah Gwynne United Kingdom · #1,082,618 worldwide 18 citations · 38 works
- 7 D. G. Lewis United Kingdom · #1,126,839 worldwide 59 citations · 23 works
- 8 Tom Crosby United Kingdom · #1,312,948 worldwide 2 citations · 27 works
- 9 Louise Hanna United Kingdom · #1,321,074 worldwide 11 citations · 19 works
- 10 W.H. Sutherland United Kingdom · #1,562,059 worldwide 20 citations · 15 works
Which keywords describe research at Velindre Cancer Centre?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Targeted Therapy, Clinical Trials, Radiotherapy, Genomic Profiling, Breast Cancer and Clinical Practice Guidelines.
- Radiation Therapy
- Surgery
- Cancer Treatment
- Preoperative Chemoradiotherapy
- Metastatic
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Prostate Cancer
- Metastatic Breast Cancer
- Endoscopic Resection
- EGFR Mutations
- Treatment Guidelines
- Adjuvant Therapy
- Genetic Mutations
- Biomarkers
- Prognostic Factors
- Clinical Practice Guidelines
- Genomic Profiling
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Clinical Trials
- Radiotherapy
- Breast Cancer
- Quality of Life
- Tumor Microenvironment
- Survival Analysis
- Precision Medicine
- Molecular Characterization
- ALK Inhibitors
- Treatment
- Neoadjuvant Therapy
- Cancer Therapy
- Clinical Guidelines
- Metastasis
- Gastric Cancer
- Hormone Therapy
- Tumor Staging
- Chemoradiation
- PET Imaging
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy7▲ 20×21 topics
- Immunotherapy5▲ 14×14 topics
- Clinical Trials5▲ 13×6 topics
- Targeted Therapy5▲ 40×4 topics
- Radiotherapy4▲ 19×11 topics
- Genomic Profiling3▲ 63×2 topics
- Breast Cancer3▲ 27×9 topics
- Clinical Practice Guidelines3▲ 11×8 topics
- Quality of Life3▲ 4.3×14 topics
- Prognostic Factors3▲ 13×11 topics
- Tumor Microenvironment3▲ 12×7 topics
- Biomarkers3▲ 7.4×5 topics
- Survival Analysis3▲ 19×6 topics
- Genetic Mutations2▲ 11×6 topics
- Precision Medicine2▲ 10×5 topics
- Adjuvant Therapy2▲ 36×2 topics
- Molecular Characterization2▲ 26×4 topics
- Treatment Guidelines2▲ 21×2 topics
- ALK Inhibitors2▲ 71×1 topic
- EGFR Mutations2▲ 71×1 topic
- Treatment2▲ 3.5×12 topics
- Endoscopic Resection2▲ 42×2 topics
- Neoadjuvant Therapy2▲ 18×5 topics
- Metastatic Breast Cancer2▲ 70×2 topics
- Cancer Therapy2▲ 6.5×7 topics
- Prostate Cancer2▲ 27×2 topics
- Clinical Guidelines2▲ 11×4 topics
- Immune Checkpoint Blockade2▲ 29×1 topic
- Metastasis2▲ 9.5×7 topics
- PD-1 and PD-L12▲ 29×1 topic
- Gastric Cancer2▲ 27×3 topics
- Metastatic2▲ 48×2 topics
- Hormone Therapy2▲ 34×3 topics
- Preoperative Chemoradiotherapy2▲ 36×2 topics
- Tumor Staging2▲ 26×2 topics
- Cancer Treatment1▲ 11×3 topics
- Chemoradiation1▲ 43×2 topics
- Surgery1▲ 7.5×5 topics
- PET Imaging1▲ 15×4 topics
- Radiation Therapy1▲ 19×4 topics
Which research topics does Velindre Cancer Centre publish most on?
By volume in 2022–2025: Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Diagnosis and Treatment and Advanced Breast Cancer Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 5 Cancer Genomics and Diagnostics Cancer Research 1 works
- 6 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 7 Esophageal Cancer Research and Treatment Surgery 1 works
- 8 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 1 works
- 9 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 1 works
- 10 Colorectal Cancer Treatments and Studies Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Velindre Cancer Centre's research output changed?
Output in 2018–2022 was 44% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cardiff
- Cardiff University
- University of Wales
- University Hospital of Wales
- Cardiff Metropolitan University
- Welsh Government
- Cardiff and Vale University Health Board
- Cardiff Royal Infirmary
- Health Economics and Outcomes Research (United Kingdom)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.